Robert A. Forbes - Concepedia

Author

Robert A. Forbes

Otsuka (United States)

Also Known As

Robert A Forbes, Robert A. Forbes, Robert Forbes, Zhao, Joan

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Otsuka (United States)Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Otsuka (Japan)Innsbruck Medical University

About

Robert A. Forbes is an author at Otsuka (United States) specializing in medicine, pharmacology, and psychopharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	932
2	Social Sciences	7	7	252
3	Engineering	2	2	25
4	Health Sciences	1	1	24
5	Biochemistry	1	1	10

Robert A. Forbes

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis Huasheng Lu, Robert A. Forbes, Ajay Verma Journal of Biological Chemistry	2002	828
Diazoxide-Induced Cardioprotection Requires Signaling Through a Redox-Sensitive Mechanism Robert A. Forbes, Charles Steenbergen, Elizabeth Murphy Circulation Research Redox SignalingCardiac MuscleCardiomyopathyHeart FailureReactive Oxygen Species	2001	392
Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia John M. Kane, Raymond Sanchez, Pamela Perry, The Journal of Clinical Psychiatry	2012	356
A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia Robert L. Findling, Adelaide S. Robb, Margaretta Nyilas, American Journal of Psychiatry	2008	265
Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole Robert L. Findling, Margaretta Nyilas, Robert A. Forbes, The Journal of Clinical Psychiatry	2009	224
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30‐week, randomized, placebo‐controlled study Robert L. Findling, Christoph U. Correll, Margaretta Nyilas, Bipolar Disorders	2013	120
Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study Suresh Mallikaarjun, John M. Kane, Patricia Bricmont, Schizophrenia Research	2013	104
Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors Yoshihiro Tadori, Robert A. Forbes, Robert D. McQuade, European Journal of Pharmacology Molecular PharmacologyFunctional SelectivityMedicinePsychopharmacologyNeuropharmacology	2008	66
Tolerability and Pharmacokinetics of Aripiprazole in Children and Adolescents With Psychiatric Disorders Robert L. Findling, Ralph E. Kauffman, Floyd R. Sallee, Journal of Clinical Psychopharmacology Drug SafetyAripiprazole PkPsychiatryPsychiatric DisordersMedicine	2008	65
Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912 Yoshihiro Tadori, Hisashi Kitagawa, Robert A. Forbes, European Journal of Pharmacology Molecular PharmacologyAgonist/antagonist PropertiesPsychiatryFunctional SelectivityMedicine	2007	65

Page 1